Innate Pharma announces conference call for third quarter 2026 business and financial update

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announces that the Company will hold a conference call on Thursday, November 5, 2026, at 2 p.m. CET / 8 a.m. ET, to provide a business and financial update for the third quarter of 2026.

Participants during the call will be: 

• Jonathan Dickinson, Chief Executive Officer
• Markus Jensen, Vice President, Chief Medical Officer
• Yannis Morel, Executive Vice President, Chief Operating Officer
• Stéphanie Cornen, Vice President, Investor Relations and Communications
• Frédéric Lombard, Senior Vice President, Chief Financial Officer

Event details:

Date and time: November 5, 2026 at 2:00 p.m. CET / 8:00 a.m. ET
Webcast link: Click here
Conference call link: Click here

This information is also available on the Investors section of the Innate Pharma website, www.innate-pharma.com. A replay of the webcast will be available on the Company website for 90 days following the event.